Related Experiment Videos
Routine-Data Nomogram for Estimating Pulmonary Hypertension Risk in Elderly Patients with Acute Exacerbation of
Mingfeng Wu1, Li Zhang2, Xiong Wang2
1Clinical Laboratory, Santai County Traditional Chinese Medicine Hospital; svfs4e@163.com.
Abstract:
Pulmonary hypertension is a clinically important complication in elderly patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease, but early risk estimation remains difficult in primary and resource-limited hospital settings. This retrospective cohort study developed and internally evaluated a routine-data-based nomogram for estimating pulmonary hypertension risk. A total of 230 elderly patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease between May 2023 and May 2025 were analyzed. Patients were classified into non-pulmonary hypertension and pulmonary hypertension groups according to transthoracic echocardiographic findings. Demographic characteristics, comorbidities, complete blood count indices, coagulation markers, inflammatory markers, and cardiac stress markers were compared between groups. Candidate predictors were selected using univariate analysis, assessment of clinical relevance, redundancy assessment, and multivariable logistic regression. Four variables-neutrophil-to-lymphocyte ratio, B-type natriuretic peptide, D-dimer, and asthma history-were independently associated with pulmonary hypertension and were incorporated into the primary nomogram. The model demonstrated good discrimination, with an area under the receiver operating characteristic curve of 0.82. Decision curve analysis indicated potential net benefit across threshold probabilities of approximately 1% to 70%. Calibration findings required cautious interpretation due to residual calibration deviation. This workflow provides a practical approach for early pulmonary hypertension risk stratification in elderly patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. However, external validation and model recalibration are required before broader clinical implementation.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Dosage Regimen Designs: Nomograms and Tabulations
Chronic Obstructive Pulmonary Disease-I: Introduction
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...